Last updated: June 5, 2026

Back to directory

Brainomix 360 Stroke medical AI product profile

Stroke imaging AI platform that supports real-time interpretation of brain scans and stroke-network coordination.

Screenshot of the official Brainomix 360 Stroke product page
Medical imaging and radiology

Best fit

Hospitals and regional stroke networks that need AI-assisted imaging triage, ASPECTS support, LVO/collateral assessment, and transfer coordination under specialist review.

Primary use case
AI-enabled CT, CTA, MRI, and mobile stroke workflow support for suspected acute stroke assessment and transfer decisions
Audience
Stroke centers, emergency departments, neuroradiology teams, transfer networks, and health systems coordinating acute stroke pathways
Risk level
High
Pricing signal
Enterprise stroke-network pricing; verify current module, mobile access, implementation, and regional terms.
Official sources
5 official sources

Compare within workflow: Medical imaging and radiology · comparison shortlist · source index

Regulatory, privacy, evidence, and workflow lens

Product-specific review. These product-specific signals summarize what the cited sources imply before treating Brainomix 360 Stroke as safe for a local clinical, operational, or research workflow.

Regulatory / FDAReview each Brainomix module separately because e-ASPECTS, e-CTA, Triage Stroke, core-volume, e-MRI, mobile alerts, and regional releases can carry different indications and clearance status.
PrivacyMap DICOM transfer, on-premises or cloud processing, pseudonymized mobile notifications, user access, retention period, secure deletion, and customer contract terms before production routing.
EvidenceEvaluate acute-stroke evidence against the local pathway, including scanner mix, ASPECTS agreement, LVO detection, core-volume estimation, false-positive burden, thrombectomy activation, and transfer outcomes.
WorkflowBest governed as specialist-reviewed stroke decision support with named responders, escalation windows, downtime handling, audit trails, and post-deployment monitoring for alert quality and treatment delays.

Where Brainomix 360 Stroke fits

Brainomix describes Brainomix 360 Stroke as an FDA-cleared and CE-marked collection of stroke imaging tools; company FDA-clearance announcements cover e-ASPECTS and non-contrast CT core-volume assessment, while Brainomix patient-data materials describe temporary server processing, pseudonymized cloud access in some workflows, and hospital-directed retention.

Not for: Autonomous stroke diagnosis, bypassing standard clinical practice, unsupported scan types, or using one cleared module as authorization for the entire stroke pathway.

What to verify before using Brainomix 360 Stroke

Source links

Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.

Related medical AI products